Literature DB >> 1886147

Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States?

D R Shopland1, H J Eyre, T F Pechacek.   

Abstract

Findings from the new American Cancer Society prospective study of 1.2 million men and women indicate that mortality risks among smokers have increased substantially for most of the eight major cancer sites causally associated with cigarette smoking. Lung cancer risk for male smokers doubled, while the risk for females increased more than fourfold. On the basis of the new American Cancer Society relative risks, we project that cigarette smoking alone will contribute to slightly more than 157,000 of the 514,000 total cancer deaths expected to occur in the United States in 1991. Overall, smoking directly contributes to 21.5% of all cancer deaths in women but 45% of all cancer deaths in men. It would also appear that lung cancer has now displaced coronary heart disease as the single leading cause of excess mortality among smokers in the United States.

Entities:  

Mesh:

Year:  1991        PMID: 1886147     DOI: 10.1093/jnci/83.16.1142

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  52 in total

1.  Lung cancer and DNA repair genes: multilevel association analysis from the International Lung Cancer Consortium.

Authors:  Rémi Kazma; Marie-Claude Babron; Valérie Gaborieau; Emmanuelle Génin; Paul Brennan; Rayjean J Hung; John R McLaughlin; Hans E Krokan; Maiken B Elvestad; Frank Skorpen; Endre Anderssen; Tõnu Vooder; Kristjan Välk; Andres Metspalu; John K Field; Mark Lathrop; Alain Sarasin; Simone Benhamou
Journal:  Carcinogenesis       Date:  2012-03-01       Impact factor: 4.944

2.  Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans.

Authors:  Yun-Ling Zheng; Christopher A Loffredo; Anthony J Alberg; Zhipeng Yu; Raymond T Jones; Donna Perlmutter; Lindsey Enewold; Mark J Krasna; Rex Yung; Peter G Shields; Curtis C Harris
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

3.  What Is the Relative Risk of Disease in Smokers?

Authors:  Miriam K Campbell
Journal:  Public Health Rep       Date:  1996-09       Impact factor: 2.792

4.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.

Authors:  G H Fisher; S L Wellen; D Klimstra; J M Lenczowski; J W Tichelaar; M J Lizak; J A Whitsett; A Koretsky; H E Varmus
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

Review 5.  Differences between studies in reported relative risks associated with smoking: an overview.

Authors:  P J van de Mheen; L J Gunning-Schepers
Journal:  Public Health Rep       Date:  1996 Sep-Oct       Impact factor: 2.792

6.  Passive smoking and lung cancer. Strength of evidence on passive smoking and lung cancer is overstated.

Authors:  P Lee
Journal:  BMJ       Date:  1998-08-01

7.  Prospective study of combined use of bronchial aspirates and biopsy specimens in diagnosis and typing of centrally located lung tumours.

Authors:  E Piaton; M H Grillet-Ravigneaux; B Saugier; H Pellet
Journal:  BMJ       Date:  1995-03-11

8.  Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.

Authors:  Gang Chen; Shaman Luo; Shannon Kozlovich; Philip Lazarus
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-09       Impact factor: 4.254

9.  Efficacy of polyphenon E, red ginseng, and rapamycin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice.

Authors:  Ying Yan; Yian Wang; Qing Tan; Yukihiko Hara; Taik-Koo Yun; Ronald A Lubet; Ming You
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

10.  Antioxidant activity of noni juice in heavy smokers.

Authors:  Mian-Ying Wang; M Nawal Lutfiyya; Vicki Weidenbacher-Hoper; Gary Anderson; Chen X Su; Brett J West
Journal:  Chem Cent J       Date:  2009-10-06       Impact factor: 4.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.